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This study investigated the interaction of ATP binding cassette (ABC) transport proteins with ivermectin
(IVM) and levamisole (LEV) in larvae of susceptible and resistant isolates of Haemonchus contortus in vitro
by measuring transcription patterns following exposure to these anthelmintics. Furthermore, we studied
the consequences of drug exposure by measuring the sensitivity of L3 to subsequent exposure to higher
drug concentrations using larval migration assays. The most highly transcribed transporter genes in both
susceptible and resistant L3 were pgp-9.3, abcf-1, mrp-5, abcf-2, pgp-3, and pgp-10. The resistant isolate
showed signiﬁcantly higher transcription of pgp-1, pgp-9.1 and pgp-9.2 compared to the susceptible
isolate. Five P-gp genes and the haf-6 gene showed signiﬁcantly higher transcription (up to 12.6-fold)
after 3 h exposure to IVM in the resistant isolate. Similarly, ﬁve P-gp genes, haf-6 and abcf-1 were
transcribed at signiﬁcantly higher levels (up to 10.3-fold) following 3 h exposure to LEV in this isolate. On
the other hand, there were no signiﬁcant changes in transcriptional patterns of all transporter genes in
the susceptible isolate following 3 and 6 h exposure to IVM or LEV. In contrast to these isolate-speciﬁc
transcription changes, both isolates showed an increase in R-123 efﬂux following exposure to the drugs,
suggesting that the drugs stimulated activity of existing transporter proteins in both isolates. Exposure of
resistant larvae to IVM or LEV resulted, in some instances, in an increase in the proportion of the pop-
ulation able to migrate at the highest IVM concentrations in subsequent migration assays. The signiﬁcant
increase in transcription of some ABC transporter genes following 3 h exposure to both IVM and LEV in
the resistant isolate only, suggests that an ability to rapidly upregulate protective pathways in response
to drugs may be a component of the resistance displayed by this isolate.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Haemonchus contortus is one of the most pathogenic gastroin-
testinal nematodes (GINs) of small ruminants, causing substantial
economic losses to livestock industries worldwide. Owing to the
unavailability of effective vaccines and/or other alternate control
methods for GINs, anthelmintics are the cornerstone of control
programs (Kaplan and Vidyashankar, 2012). However, resistance
has developed to all the major classes of anthelmintics and this
situation threatens the sustainability of many livestock enterprisesody Rd., St. Lucia, QLD 4067,
).
Ltd on behalf of Australian Society f(Kaplan, 2004; Sutherland and Leathwick, 2011).
A number of studies have shown that nematode ATP binding
cassette (ABC) transport proteins (including P-glycoproteins (P-
gps), multi-drug resistance proteins (MRPs) and Half (HAF) trans-
porters) have a protective function through their role in the efﬂux
of anthelmintics (Kerboeuf and Guegnard, 2011; Lespine et al.,
2012; Janssen et al., 2013, 2015; Kaschny et al., 2015). Increased
expression of P-gps in nematodes after in vitro as well as in vivo
exposure to anthelmintics suggests a role for P-gps in the efﬂux of
anthelmintics (Dicker et al., 2011; Williamson et al., 2011; De Graef
et al., 2013). The reported increase in sensitivity to some anthel-
mintics, particularly IVM, in different P-gp knock-out strains of
Caenorhabditis elegans, also provides evidence for their role in
protection from anthelmintics (Ardelli and Prichard, 2013; Bygarskior Parasitology. This is an open access article under the CC BY-NC-ND license (http://
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to anthelmintics, with a number of studies describing an increased
transcription of speciﬁc transporter genes in drug-resistant nem-
atodes (Dicker et al., 2011; Williamson et al., 2011; Sarai et al.,
2014). Increased expression levels of several P-gps and MRP
genes have been reported in C. elegans post-exposure to IVM (James
and Davey, 2009; Ardelli and Prichard, 2013). Similarly, in parasitic
nematodes, overexpression of pgp-11, pgp-16 and mrp-1 was
observed in Cooperia oncophora recovered from animals treated
with IVM (De Graef et al., 2013; Tyden et al., 2014), while Lloberas
et al. (2013) reported that treatment of infected lambs with IVM
increased the transcription levels of pgp-2 in resistant worms of
H. contortus compared to worms collected from untreated control
animals. The use of multi-drug resistance inhibitors (MDRIs) to
increase the toxicity of anthelmintics to nematodes further in-
dicates a role for drug transporters in resistance (Bartley et al.,
2009; Heckler et al., 2014; Raza et al., 2015).
Nematodes possess a greater diversity of MDR transporters
compared to mammals. C. elegans is known to possess 15 P-gp
genes, eight MRP and nine Haf genes (Sheps et al., 2004). In para-
sitic nematodes, 11 P-gp genes, one HAF gene and two MRP genes
have been reported in H. contortus (Williamson andWolstenholme,
2012; Laing et al., 2013). Furthermore, eight P-gp genes, ﬁve MRP
genes and eight HAF genes were identiﬁed in Brugia malayi (Ardelli
et al., 2010), two P-gp genes in cyathostomins (Drogemuller et al.,
2004) and 11 partial sequences of P-gp genes have been reported
in Teladorsagia circumcincta (Dicker et al., 2011). The diversity of
nematode P-gps suggests that theymay play a protective role in the
efﬂux of a wide range of environmental toxins and internal me-
tabolites (Prichard and Roulet, 2007).
The aim of the present study was to examine transcription
patterns of ABC transporters in the third-stage larvae (L3) of
H. contortus. Firstly, we examined the relative transcription levels of
the various transporter genes in L3 of susceptible and -resistant
isolates of the parasite, and identiﬁed differences between tran-
scription levels of the various genes within each isolate, and be-
tween the two isolates. We then measured gene transcription
patterns in both susceptible and -resistant L3 following exposure to
IVM and LEV in vitro. Finally, we examined the functional conse-
quences of this drug exposure by measuring efﬂux of the dye
rhodamine-123 (R-123) from drug-exposed and control worms,
and also by using migration assays to measure the sensitivity of
larvae to IVM and LEV following pre-treatment with lower con-
centrations of these drugs.
2. Materials and methods
2.1. Parasites
Two isolates of H. contortus were used for the present study:
(i) Kirby: isolated from the ﬁeld at Kirby Research Farm, Uni-
versity of New England in 1986; susceptible to all commer-
cially available anthelmintics (Albers and Burgess, 1988).
(ii) Wallangra (WAL): isolated in 2003 from the New England
region of Northern New South Wales (NSW). At the time of
isolation from the ﬁeld, WAL was resistant to benzimid-
azoles, closantel, LEV and IVM (Love et al., 2003). The isolate
has further been selected against moxidectin (Cydectin®) for
at least ﬁve generations.
Infected animals were housed at the Commonwealth Scientiﬁc
and Industrial Research Organisation (CSIRO) Agriculture FD
McMaster laboratory at Armidale, NSW. All animal procedures were
approved by the FD McMaster Animal Ethics Committee, CSIROAgriculture Flagship (Animal Ethics Approval Number AEC 13/23).
Faeces was collected from infected sheep, placed into large
ziplock bags, and sent by courier to the CSIRO Agriculture labora-
tories at the Queensland Bioscience Precinct, Brisbane, Queensland.
For recovery of L3, the faecal samples were placed into 2L glass jars
and most of the faecal pellets were broken up by hand. The faecal
mixture was slightly moistened with tap water, and the jars were
then placed in an incubator at 27 C. After approximately oneweek,
the L3 moving up the sides of the jar were ﬂushed out with tap
water, placed onto a cloth (20 mm) suspended inwater, and allowed
to migrate into a collection jar overnight. Collected L3 were stored
at 15 C for the later use in migration and molecular assays within
three to four weeks.
2.2. RNA extraction and generation of complementary (c)DNA
Approximately 30,000 L3 were used for each RNA preparation.
Total RNAwas extracted using RNeasy mini kit (Qiagen®, Germany)
following the manufacturer's protocol. Brieﬂy, the samples were
homogenised in buffer RLT using a bead-based homogenizer (Po-
wer-lyzer® 24, Mo-Bio Laboratories, USA) followed by washing,
binding and elution of total RNA. The extracted RNA was treated
with Turbo-DNase (Ambion®, USA) to remove genomic DNA. RNA
samples were quantiﬁed using a spectrophotometer (Nanodrop
8000, Thermo Scientiﬁc®, USA) and stored at80 C for further use.
cDNA was synthesised using DNase-treated RNA with Superscript
III™ reverse transcriptase (Invitrogen®, USA) according to the
manufacturer's instructions. The ﬁnal volume of cDNA was diluted
to a concentration of 4 ng/mL for downstream applications. For each
of the isolate and/or treatment, cDNA was generated in three
distinct replicates using separate worm samples for subsequent
gene expression analysis.
2.3. Quantitative PCR (qPCR)
Primer sequences for some of the ABC-transporters used herein
were previously reported by Sarai et al. (2013) (GAPDH, actin, pgp-1.
pgp-2, pgp-3, pgp-10, pgp-12 and pgp-14) and Issouf et al. (2014)
(pgp-9.2 and pgp-16). Primers for b-tubulin, pgp-9.1, pgp-9.3, pgp-
11,mrp-1,mrp-5, haf-6, and ABCF transporters were designed using
Primer-3 from the sequence information available on Nembase-4
(see Supplementary Table 1). Three housekeeping genes, GAPDH,
actin and b-tubulin, were used as reference genes for the qPCR
analyses. Approximately 18 ng of cDNA was added to other stan-
dard PCR reagents in a total reaction volume of 25 mL and then split
into four replicates, each of 5 mL. A Vii A7 thermocycler® (Applied
Biosystems, USA) was used with SYBR® Green dye system (Applied
Biosystems, USA) under the following PCR cycling conditions: 50 C
for 2 min, 95 C for 10 min, followed by 40 cycles of 95 C for 15 s,
60 C for 1 min, followed by a melt curve stage (95 C for 15 s, 60 C
for 1 min and 95 C for 15 s). Each sample was represented by three
biological replicates and run in four technical replicates in the real-
time PCR. Ampliﬁcation efﬁciency for each primer set was deter-
mined by performing PCR using either 2-fold or 1.5-fold cDNA di-
lutions. Standard curves for all primers showed an efﬁciency range
between 80 and 99%. Melt-curves were analysed for each primer
sequence to ensure the speciﬁcity of the primers. Furthermore, the
PCR products were run on an electrophoresis gel and viewed under
UV illumination after SYBR safe staining to ensure that a single
band without any non-speciﬁc product was visible. In order to
conﬁrm the identity of the PCR products generated using primers
designed for the present study (pgp-9.1, pgp-9.3,mrp-1,mrp-5, abcf-
1 and abcf-2), the products were cloned into Top-10 cells (Invi-
trogen®, USA) and sequenced (Big-Dye terminator, V3.1; Applied
Biosystems, USA) using M13 forward/reverse primers. In each case,
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Expression values for all genes in each sample were normalised
to the three housekeeping genes using REST 2009 (version v2.0.13)
to: (1) determine the transcription levels of each gene within an
isolate using the transcription level of pgp-1 as control; (2) compare
the transcription proﬁles of ABC transporter genes between resis-
tant and susceptible isolates, and (3) measure the transcriptional
patterns of ABC transporters post-exposure to IVM and LEV (drug
exposure regimen described below in section 2.4) using DMSO-
treated samples as controls for each isolate. In order to compare
the transcription proﬁles of control and test samples, the triplicate
expression values were log10-transformed and analysed using
repeated measures ANOVA with Fischer's LSD as multiple com-
parison test in GraphPad Prism® software (GraphPad Prism, USA
version 6.01).
2.4. Drug exposure assays
Technical grade IVM and LEV were purchased from Sigma-
eAldrich. For each anthelmintic, a stock solution was prepared at
10mg/mL in dimethyl sulfoxide (DMSO) followed by two-fold serial
dilutions in DMSO to produce multiple separate anthelmintic
solutions.
To measure the effects of drug exposure on the expression
proﬁles of ABC transporters, groups of approximately 30,000 L3
were exposed to IVM (0.2 and 0.8 mg/mL), LEV (0.4 mg/mL) or DMSO
(vehicle control) for two different time periods (3 and 6 h). These
selected concentrations were based on the doseeresponse curves
described previously (Raza et al., 2015). The lower (0.2 mg/mL)
concentration of IVM was non-toxic to resistant isolate, but
inhibited about 12% of the larval migration for the susceptible
isolate, whereas, the higher concentration of IVM (0.8 mg/mL)
showed about 12% and 25% inhibition of larval migration in the
resistant and susceptible isolates, respectively. The LEV concen-
tration (0.4 mg/mL) showed about 10% inhibition of larval migration
with both the isolates (Raza et al., 2015). The concentration of
DMSO across all the treatments was 1% (v/v).
The worms were kept on a roller-mixer (BTR-5, Ratek®,
Australia) for the entire duration of the drug-exposure period. Both
the susceptible and resistant isolates were examined in three
separate experiments. After exposure, the worms were snap frozen
in liquid nitrogen and kept at 80 C for further use. The tran-
scriptional proﬁles of 11 P-gps, two MRPs, one HAF and two ABCF
genes were measured by qPCR as described above (Section 2.3).
2.5. Larval migration assay (LMA)
An LMAwas used to determine the sensitivity of Kirby andWAL
L3 larvae to a range of concentrations of IVM and LEV following 3 h
drug-exposure for Kirby and 3 and 6 h drug-exposure for WAL as
described in Section 2.4. The LMA was modiﬁed from Kotze et al.
(2006) as follows: (1) the assays used short incubation/migration
periods (30 min each) compared to 48 and 24 h periods in the
earlier paper, (2) ﬁlter-mesh plateswere usedwithout any agar, and
(3) receiver plate wells received only 300 mL water and no drug.
Final concentration ranges used for IVM were 100e0.195 mg/mL
and 12.5e0.024 mg/mL for LEV. Three separate experiments (each
with assays in triplicate) were run for each combination of pre-
exposure treatment (IVM at 0.2 mg/mL and 0.8 mg/mL or LEV at
0.4 mg/mL) and subsequent dose response (range of IVM or LEV
concentrations) with the resistant Wallangra isolate. Assays with
the Kirby isolate were only performed using L3 pre-exposed to the
lower IVM concentration (0.2 mg/mL), as well as LEV (0.4 mg/mL), as
a previous study had shown that the migration of Kirby larvae was
reduced by 25% at the higher IVM concentration compared tocontrols (Raza et al., 2015), hence making it difﬁcult to accurately
measure the speciﬁc effects of subsequent drug exposure.
The datawere analysed using non-linear regression in GraphPad
Prism® software (GraphPad Prism, USA version 6.01). IC50 values
and 95% conﬁdence intervals were calculated based on the pooled
data from each set of nine assays, and signiﬁcant differences were
determined by the overlap of 95% conﬁdence intervals. For assays
with LEV, the larvae showed % migration ranging from approxi-
mately 100% (equivalent to controls) down to 0% migration, and
hence we used a normalised doseeresponse model in GraphPad
(doseeresponse from 100% to 0%), and a variable slope. On the
other hand, the dose response to IVM in the migration assay
showed the presence of a plateau in response at the highest drug
concentrations. The % migration remained at a constant level
(above 0%) over the highest 3 to 4 drug concentrations. Hence, for
the analysis of the IVM doseeresponse data we used a non-
normalised model in GraphPad (‘top to bottom’), with a variable
slope. The output of this analysis provided us with two parameters
with which to compare populations: ﬁrstly, the % migration at the
doseeresponse plateau (that is, the % of the population unaffected
by the highest concentrations of IVM in the assay), and secondly,
the IC50 in the remaining proportion of the population that had
shown a doseeresponse to the drug (for instance, if the plateau
existed at a level of 40% migration, then the IC50 value deﬁned the
response to the drug in the remaining 60% of the worm population
alone).
2.6. Rhodamine-123 efﬂux assay
Efﬂux of rhodamine-123 from larvae following exposure to IVM
and LEV was measured using an assay modiﬁed from Kerboeuf and
Guegnard (2011). Brieﬂy, for each isolate, approximately 20,000 L3
were exposed to IVM (at 0.2 mg/mL and 0.8 mg/mL), LEV at 0.4 mg/mL
or 1% DMSO for 3 h, as described above in Section 2.4. Following
exposure to drugs, the worms were centrifuged (3000g, 1 min), the
supernatant was discarded, and the worm pellet washed using
1 mL distilled water. R-123 solution (2 mL of 1.5 mM) was added to
the worm pellet which was then placed on a roller for 15 min in the
dark at room temperature (¼ R-123 accumulation period). At the
end of the accumulation period, the worms were centrifuged
(3000g, 1 min), followed by washing in 1 mL of water. The worm
pellet was resuspended in water (1 mL) and placed on a roller-
mixer (BTR-5, Ratek®, Australia) in the dark for 60 min (¼ R-123
efﬂux period). The worms were sedimented by centrifugation
(3000g, 1 min) and the supernatant was collected and stored at
room temperature for 60min in the dark before analysis. R-123was
detected using a ﬂuorescence spectrophotometer (SpectraMaxM3,
Molecular Devices®, USA) (l for excitation ¼ 495 nm and l for
emission ¼ 525 nm). Three separate experiments were performed,
each with duplicate assays. The concentration of R-123 in each
experimental sample was calculated from a standard curve deter-
mined using a range of concentrations of R-123. The pooled data
(n ¼ 6 for each treatment) were Log10-transformed and analysed
using repeated measures ANOVA followed by Fischer's LSD
(GraphPad Prism, USA version 6.01).
3. Results
3.1. Basal transcription levels of ABC transporters in resistant and
susceptible isolates of H. contortus
In the susceptible isolate, transcription of all the P-gp, MRP and
ABCF genes was signiﬁcantly higher (P < 0.05) than for the pgp-1
gene (Fig. 1A and C). The pattern observed in the resistant isolate
was similar, except that pgp-11 and pgp-16were at equivalent levels
Fig. 1. Basal transcription levels of ABC transporter genes in susceptible (A) and resistant (B) isolates of Haemonchus contortus compared to the transcription levels of pgp-1. Data
shown as mean ± SEM, n ¼ 3 separate experiments each with four technical replicates. Signiﬁcant differences in the relative transcription of the genes within each isolate are
indicated in part (C). Gene transcription levels relative to pgp-1 are ranked from the highest to the lowest; genes grouped together with vertical lines did not show signiﬁcant
differences in transcription levels (at P < 0.05).
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lower (P > 0.05) than pgp-1 in both isolates. Compared to pgp-1,
transcription of pgp-9.3 was increased by 136-fold and 83-fold in
the susceptible and resistant isolates, respectively. The other
markedly higher transcription levels, relative to pgp-1, were for
abcf-1 (85-fold higher in susceptible, and 52-fold higher in resis-
tant), mrp-5 (68- and 42-fold), abcf-2 (61- and 31-fold), pgp-3 (50-
fold and 26-fold), and pgp-10 (37- and 29- fold).
A comparison of the transcription levels of the ABC transporter
genes in resistant (WAL) and susceptible (Kirby) isolates showed
that pgp-1, pgp-9.1 and pgp-9.2 were transcribed at signiﬁcantly
higher levels in the former isolate (P ¼ 0.04, 0.03, and 0.02,
respectively) (Fig. 2). Transcription levels were increased inWAL by
2.5-fold for pgp-1 and pgp-9.2, and 3-fold for pgp-9.1. There were no
signiﬁcant differences in transcription levels for all the other
transporters, including MRPs, ABCFs and the haf-6 gene, between
the two isolates.Fig. 2. Relative transcription levels of ABC transporter genes in resistant (WAL)
compared to susceptible (Kirby) isolates of Haemonchus contortus. Signiﬁcant differ-
ences in the transcription between the two isolates are indicated by * (P < 0.05). Data
shown as mean ± SEM, n ¼ 3 separate experiments, each with four technical replicates.3.2. Transcription levels of ABC transporters in resistant and
susceptible isolates of H. contortus following exposure to IVM
There were no signiﬁcant changes in transcription proﬁles of all
16 ABC transporter genes in the susceptible isolate following 3 or
6 h exposure to IVM at 0.2 mg/mL compared to control worms
(exposed to DMSO alone) (Fig. 3A and B). The data at the 6 h time
point revealed a degree of variability among different replicates as
reﬂected in the large standard error (SE) bars in some cases in
Fig. 3B, however, none of the genes showed a statistically signiﬁ-
cant change relative to controls. In contrast, ﬁve P-gp genes and the
haf-6 gene were signiﬁcantly up-regulated in the resistant isolateafter exposure to IVM at 0.2 mg/mL for 3 h (Fig. 3C). The magnitude
of these increases were as follows: 12.6-fold for haf-6 (P < 0.0001),
9.1-fold for pgp-2 (P < 0.0001), 6.4-fold for pgp-9.1 (P ¼ 0.0006),
6.4-fold for pgp-11 (P ¼ 0.0004), 3.6-fold for pgp-1 (P ¼ 0.02), and
3.1-fold for pgp-10 (P ¼ 0.02). These increased transcription levels
were however quite temporary, as by 6 h of exposure to this con-
centration of IVM, the resistant isolate showed no changes in
transcription of any of the transporter genes relative to DMSO-
Fig. 3. Effects of IVM (0.2 mg/mL) on transcription patterns of ABC transporter genes in the third-stage larvae of susceptible (A at 3 h and B at 6 h) and resistant (C at 3 h and D at 6 h)
isolates of Haemonchus contortus compared to DMSO controls. Y-axis shows fold-change in gene expression levels in drug-treated vs DMSO-treated larvae. Data shown as
mean ± SEM, n ¼ 3 separate experiments, each with four technical replicates. Signiﬁcant differences in gene transcription levels are indicated by * (P < 0.05).
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The results of IVM-exposure experiments at a concentration of
0.8 mg/mL are shown in Fig. 4. Again, as seen at 0.2 mg/mL, the only
signiﬁcant instances of altered gene transcriptionwere increases in
IVM-exposed resistant isolate larvae at the 3 h time point (Fig. 4C).
There were no signiﬁcant changes in any of the genes for the sus-
ceptible isolate at 3 or 6 h, however, as noted above for the 0.2 mg/
mL data, there was a degree of variability between replicate ex-
periments which resulted in large SEs in some cases, particularly
for pgp-9.1 at the 6 h time point (Fig. 4B). The magnitudes of the
increases observed for the resistant isolate at 3 h were as follows:
pgp-2 4.5-fold (P¼ 0.0001), pgp-9.1 2.6-fold (P¼ 0.005), pgp-11 2.3-
fold (P ¼ 0.01) and haf-6 2.4-fold (P ¼ 0.03). By the 6 h time point,
transcription levels in the resistant isolate had returned to control
levels (Fig. 4D), as was observed for the 0.2 mg/mL treatment.
Comparison of the 0.2 and 0.8 mg/mL data sets showed that the
increases in gene transcription were 2e3 fold lower for the P-gp
genes (pgp-2, 9.1 and 11) and 6-fold lower for the haf-6 gene at the
higher IVM concentration.3.3. Transcription levels of ABC transporters in resistant and
susceptible isolates of H. contortus following exposure to LEV
Exposure to LEV at 0.4 mg/mL did not affect transcription levels
of any of the transporter genes in the susceptible isolate for both
the 3 and 6 h exposure treatments (Fig. 5A and B). In contrast, 3 hexposure of the resistant isolate resulted in signiﬁcant up-
regulation of a number of genes: pgp-1 3.5-fold (P ¼ 0.0003), pgp-
2 9.6-fold (P < 0.0001), pgp-9.1 6.5-fold (P < 0.0001), pgp-10 3-fold
(P ¼ 0.0007), pgp-11 6-fold (P < 0.0001), abcf-1 2-fold (P ¼ 0.03),
and haf-6 10.3-fold (P < 0.0001) (Fig. 5C). There was a single
instance of down-regulation, with pgp-16 showing a signiﬁcant
decrease (2-fold) (P ¼ 0.04) at 3 h exposure relative to the DMSO
control. Interestingly, pgp-11 remained up-regulated (2.6-fold) after
6 h pre-exposure to LEV at 0.4 mg/mL (Fig. 5D), representing the
only instance of signiﬁcantly altered transcription (P ¼ 0.04) at this
time point across the entire set of IVM and LEV exposure
experiments.3.4. Functional consequences of increased transcription of
transporter genes
3.4.1. Larval migration assay
The functional consequences of increased transcription of
transporter genes following exposure to IVM and LEV were exam-
ined using larval migration assays tomeasure the ability of IVM and
LEV to inhibit migration in larvae of the susceptible and resistant
isolates that had previously been exposed for 3 or 6 h to low levels
of the two drugs (the same concentrations as used for the gene
expression experiments) compared to DMSO-treated controls
(Figs. 6 and 7; Tables 1 and 2). A feature of the IVM dose-responses
in these experiments was the presence of a plateau in the response
Fig. 4. Effects of IVM (0.8 mg/mL) on transcription patterns of ABC transporter genes in the third-stage larvae of susceptible (A at 3 h and B at 6 h) and resistant (C at 3 h and D at 6 h)
isolates of Haemonchus contortus compared to DMSO controls. Y-axis shows fold-changes in gene expression levels in drug-treated vs DMSO-treated larvae. Data shown as
mean ± SEM, n ¼ 3 separate experiments, each with four technical replicates. Signiﬁcant differences in gene transcription levels are indicated by * (P < 0.05).
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proportion of the worm population remained able to migrate
through the ﬁlter-mesh system at the highest drug concentrations.
Our analysis of these dose response curves provided two parame-
ters for comparing the effects of the drug pre-treatments, namely,
the % of the population that was unaffected by the high IVM con-
centrations (the doseeresponse plateau), and the IC50 value derived
from the doseeresponse shown by the remainder of the popula-
tion. Pre-exposure for 3 h to IVM at 0.8 mg/mL resulted in a sig-
niﬁcant increase in the % of larvae able to migrate at the highest
drug concentrations (plateau increased from 17.6% to 48.1%),
alongside no change in the IC50 of the remaining population
(Fig. 6A, Table 1). Pre-exposure to IVM at the lower concentration
(0.2 mg/mL) resulted in no change to the migration plateau,
alongside a decrease in the IC50 (to 0.63 of the control). Pre-
exposure to LEV (0.4 mg/mL) resulted in a signiﬁcant increase in
the proportion of the population unaffected by the highest drug
concentrations (from 17.6 to 30.7%), alongside a decrease in the IC50
in the remainder of the population (to 0.57 of the control). The
effects of 6 h pre-exposure to IVM at 0.8 mg/mL and LEV at 0.4 mg/
mL, were similar to those seen after 3 h, with signiﬁcant increases
in the IVM dose response plateau (from 15.5% in controls to 25.4
and 31.3% in L3 pre-treated with IVM and LEV, respectively),
although in this case there was no decrease in the LEV IC50 as had
been observed after 3 h pre-exposure (Fig. 6B, Table 1). The
response to IVM after 6 h pre-exposure to the same drug at 0.2 mg/
mL was similar to that observed after 3 h, with no change in thedose response plateau and a decrease in the IC50 for the remaining
population (to 0.60 of the control). Overall, two effects were
apparent: an increase in the proportion of the population able to
migrate at the highest IVM concentrations following exposure to
IVM at 0.8 mg/mL and LEV at 0.4 mg/mL, alongside a number of in-
stances of decreased IC50 in the remainder of the population,
indicating the presence of instances of increased drug tolerance
(higher plateau) as well as increased drug sensitivity (lower IC50) in
different components of the worm populations. After 3 h pre-
exposure to LEV, these aspects of increased and decreased sensi-
tivity to IVM in the two separate components of the population
occurred simultaneously.
LEV IC50 values were signiﬁcantly decreased following 3 h pre-
exposure to IVM (0.2 or 0.8 mg/mL) (to 0.49 or 0.33 of control)
and LEV (0.4 mg/mL) (to 0.28 of control) (Fig. 6C; Table 2). Similarly,
following 6 h pre-exposure to IVM or LEV, the L3 showed increased
sensitivity to LEV (IC50 decreased to 0.43 of control for IVM pre-
exposure, and 0.33 of control for LEV pre-exposure) (Fig. 6D;
Table 2).
In the susceptible isolate, pre-exposure to IVM (0.2 mg/mL) and
LEV (0.4 mg/mL) did not result in any signiﬁcant changes to the IVM
dose response plateau, although the IC50 was reduced following
pre-treatment with IVM at 0.2 mg/mL (to 0.72 of control) (Fig. 7A;
IC50 and plateau data not shown). Pre-exposure to IVM (0.2 mg/mL)
resulted in increased sensitivity to LEV (IC50 reduced to 0.29 of
control), alongside no change in LEV response following pre-
exposure to this same drug (Fig. 7B).
Fig. 5. Effects of LEV (0.4 mg/mL) on transcription patterns of ABC transporter genes in the third-stage larvae of susceptible (A at 3 h and B at 6 h) and resistant (C at 3 h and D at 6 h)
isolates of Haemonchus contortus compared to DMSO controls. Y-axis shows fold-change in gene expression levels in drug-treated vs DMSO-treated larvae. Data shown as
mean ± SEM, n ¼ 3 separate experiments each with four technical replicates. Signiﬁcant differences in gene transcription levels are indicated by * (P < 0.05).
A. Raza et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 103e115 1093.4.2. Rhodamine-123 efﬂux assay
The functional consequences of drug pre-exposure were further
evaluated by observing the effects of the drug treatments on the
ability of L3 to efﬂux the ﬂuorescent dye R-123 (Fig. 8). In both
resistant and susceptible isolates, exposure to IVM (0.8 mg/mL) and
LEV (0.4 mg/mL) for 3 h signiﬁcantly increased (P < 0.05) the efﬂux
of R-123 compared to the DMSO-treated control worms. In
contrast, pre-exposure to the lower concentration of IVM (0.2 mg/
mL) did not result in any change in R-123 efﬂux in both the isolates
(Fig. 8).
The levels of R-123 efﬂux were equivalent in resistant and
susceptible L3 in the absence of any drug exposure (DMSO-treated)
(P ¼ 0.07).
4. Discussion
The present study represents the ﬁrst description of the relative
transcription levels of the suite of drug transporter genes in a
parasitic nematode. We measured the transcription levels for each
ABC transporter gene within a susceptible and resistant isolate and
then described these levels relative to pgp-1within each isolate. The
ranking of transcription levels from the highest to the lowest was
similar, but not identical, in the two isolates. The same set of genes
(pgp-9.3, abcf-1, mrp-5, abcf-2, pgp-10 and pgp-3) were transcribed
at the highest levels in both isolates. The haf-6 genewas transcribed
at the lowest levels in both isolates. The protective functions of
several of these ABC transporters have been reported previously.Pgp-3 acts in protection against natural toxins in C. elegans (Broeks
et al., 1995). Issouf et al. (2014) described the speciﬁc induction of
pgp-3 in H. contortus exposed to sheep eosinophil granules as
suggesting a role in detoxiﬁcation of host immune cell products. In
addition, the expression of some P-gp genes (including pgp-3 and
pgp-9) in intestinal excretory cells of the closely related model or-
ganism C. elegans, further suggests a role for them in the protection
of worms against toxic substances (Ardelli and Prichard, 2013). We
also observed relatively high expression levels of ABCF transporters
(abcf-1 and abcf-2) compared to many of the other genes. ABCF
transporters lack the transmembrane domains (TMDs) present in
other transporter proteins, and their function as transporters is
currently unclear. It has been suggested that ABCF transporters are
involved in cell physiology (ribosome assembly, translational con-
trol and mRNA transport) in arthropods (Dermauw and Van
Leeuwen, 2014). Furthermore, it has been reported that absence
of ABCF transporters in arthropods results in physical abnormalities
as shown by Broehan et al. (2013) who observed the death of L3 and
arrested growth, as well as the death as pharate adults, in RNA
interference studies with L3 and pupae of Tribolium castaneum,
respectively. However, the role of these transporters in gastroin-
testinal nematodes remains to be determined.
The transcription levels for pgp-1, pgp-9.1 and pgp-9.2 were
signiﬁcantly greater in the drug-resistant WAL isolate compared to
the drug-susceptible Kirby isolate. This ﬁnding is in agreement
with the earlier report by Sarai et al. (2013) who described an up-
regulation of pgp-1 and pgp-9 in L3 of the WAL isolate compared
Fig. 6. Effects of IVM (0.2 and 0.8 mg/mL) and LEV (0.4 mg/mL) pre-exposure on tolerance to IVM (A after 3 h pre-exposure and B after 6 h pre-exposure) and LEV (C at 3 h pre-
exposure and D at 6 h pre-exposure) in the third-stage larvae of the resistant isolate of Haemonchus contortus in larval migration assays. Each data point represents mean ± SE, n ¼ 9
(pooled data from three experiments, each with assays in triplicate).
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homologues of pgp-9 (as their existence was unknown at that time)
and hence the present study has extended the earlier ﬁndings by
showing that the increase in transcription of pgp-9 reported earlier
was most-likely associated with increases for pgp-9.1 and 9.2,
alongside no change in pgp-9.3. The expression patterns of P-gps in
nematodes seem to be quite variable, with some reports linking
them to anthelmintic resistance and other studies ﬁnding no as-
sociation.Williamson et al. (2011) reported a signiﬁcantly increased
expression of pgp-2 and pgp-9 in a multi-drug resistant isolate
compared to a susceptible isolate, alongside a signiﬁcant decrease
in pgp-1 transcription. In contrast, Williamson and Wolstenholme
(2012) found no changes in P-gp transcription in a laboratory
selected IVM-resistant isolate compared to its drug-sensitive
parent. In addition, there have been reports describing increased
transcription of pgp-9 in ML-resistant T. circumcincta adult worms,
and of haf-9 andmrp-1 in eggs of IVM resistant C. oncophora (Dicker
et al., 2011; De Graef et al., 2013). The increased transcription of
several P-gps in resistant L3 in the present study suggests that they
may play a role in the anthelmintic resistance shown by the multi-
drug resistant WAL isolate. However, conﬁrmation of any such as-
sociation requires studies measuring actual drug efﬂux from larval
and adult life-stages of susceptible and resistant isolates. Our R-123
efﬂux measurements showed that the rate of efﬂux was equivalent
in the susceptible and resistant L3. This may be expected, despite
the up-regulation of several transporter genes in the resistant
isolate, as these speciﬁc transporters (pgp-1, pgp-9.1 and pgp-9.2)
were expressed at low levels compared to most of the other
transporter genes (from Fig. 1C). Hence, increased transcription ofjust these three genes would likely have little or no impact on the
total efﬂux activity measured using a general substrate such as R-
123.
Substrates of ABC transporters are known to regulate the
expression levels of P-gps and other ABC transporters through
transcriptional or post-transcriptional mechanisms (Schrenk et al.,
2001). There is a great deal of literature available on the inducing
effects of various agents on P-gp expression levels in mammals
(Lespine et al., 2012; Menez et al., 2012; Yu et al., 2013). The
experimental evidence of up-regulation in nematodes in response
to exposure to anthelmintics is limited and inconsistent. Up-
regulation of several P-gp genes has been observed in ML resis-
tant C. elegans (James and Davey, 2009; Yan et al., 2012; Ardelli and
Prichard, 2013). Induction of P-gps was observed in H. contortus
(pgp-2) and C. oncophora (pgp-16 and mrp-1) adult worms after
in vivo exposure to IVM (Lloberas et al., 2013; Tyden et al., 2014).
Furthermore, De Graef et al. (2013) also reported a signiﬁcant in-
crease (3e5 fold) in transcription levels of pgp-11 in C. oncophora
adult worms 14 days after treatment with IVM or moxidectin
compared to non-exposed adults. However, there were no signiﬁ-
cant differences observed between the expression patterns of P-gp
genes before and after IVM treatment in C. oncophora and
H. contortus (Williamson and Wolstenholme, 2012; Areskog et al.,
2013).
We examined the effects of exposure to low levels of IVM and
LEV on the transcription proﬁles of ABC transporters in H. contortus
L3. Exposure to IVM and LEV for 3 h resulted in increased tran-
scription of multiple ABC transporter genes in the resistant isolate
only. The patterns of up-regulation were very similar for IVM and
Fig. 7. Effects of IVM (0.2 mg/mL) and LEV (0.4 mg/mL) pre-exposure for 3 h on toler-
ance to IVM (A) and LEV (B) in the third-stage larvae of the susceptible isolate of
Haemonchus contortus in larval migration assays. Each data point represents
mean ± SE, n ¼ 9 (pooled data from three experiments, each with assays in triplicate).
Table 1
Response of third-stage larvae of the resistant isolate of Haemonchus contortus (Wallanga
mL) or LEV (0.4 mg/mL) in larval migration assays.
Pre-
exposure
Ivermectin doseeresponse
3 h pre-exposure
IC50 Dose-response plateau
Drug conc.a mg/
mL
95% CI Drug/
DMSOa,b
Migrationc
(%)
95% CI Drug/
DMSOc,d
DMSO 4.03 3.51
e4.63
e 17.6 12.7
e22.5
e
IVM 0.2 mg/
mL
2.55* 2.11
e3.07
0.63* 17.6 13.0
e22.0
1
IVM 0.8 mg/
mL
3.04 2.21
e4.19
0.75 48.1* 42.6
e53.7
2.7*
LEV 0.4 mg/
mL
2.31* 1.79
e2.99
0.57* 30.7* 24.7
e36.5
1.7*
a Within either the 3 or 6 h pre-exposure data sets:* denotes that the IC50 following
exposure to DMSO, as determined by non-overlap of 95% Conﬁdence Intervals.
b Drug/DMSO ¼ IC50 for IVM following pre-exposure to anthelmintics/IC50 for IVM fol
c Within either the 3 or 6 h pre-exposure data sets:* denotes that L3 migration (%) at t
higher than L3 migration (%) at the plateau following pre-exposure to DMSO, as determ
d Drug/DMSO ¼ L3 migration (%) at the doseeresponse plateau for IVM following pre
exposure to DMSO.
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-2, -9.1, -10, -11, and haf-6, while LEV exposure also resulted in up-
regulation of abcf-1. Given the resistance shown by this isolate to-
wards both IVM and LEV, it is noteworthy that two of the genes that
responded to drug exposure (pgp-1, and pgp-9.1) were also shown
to be constitutively over-expressed in this isolate compared to the
susceptible Kirby isolate (Fig. 2). Surprisingly, the increases in
transcript levels following IVM treatment were greater at the lower
IVM concentration (0.2 mg/mL) than at the higher concentration
(0.8 mg/mL) (compare Figs. 3C and 4C). There are two possible ex-
planations for this. Firstly, as noted in Section 2.4, the lower IVM
concentration did not affect migration of the resistant larvae, as
reported by Raza et al. (2015), while the higher IVM concentration
resulted in 12% inhibition of migration. Thus, the larvae exposed to
this higher concentration may have been compromised to some
degree in their ﬁtness, resulting in a lower gene induction response
compared to the larvae exposed to the lower concentration. Sec-
ondly, it may be possible that greater increases in transcription
occurred with 0.8 mg/mL IVM at an earlier time than the 3 h time
point examined in our experiments. Ardelli et al. (2009) showed
that glc-1 transcript increases in C. elegans were much more pro-
nounced after exposure to 10 nM IVM compared to 2.5 nM IVM at
the 0.5 h time point, while the pattern was reversed after 2.5 h of
drug exposure, with the fold increases in transcription being much
greater at the lower IVM concentration by that time.
The up-regulation response of the resistant larvae to drug
exposure was quite short-lived. By the 6 h time point, gene tran-
scription had returned to the same levels as shown by DMSO-
treated controls. The only exception to this was the continued up-
regulation of pgp-11 after 6 h exposure to LEV in resistant L3. Pre-
viously, it was observed that more P-gp genes were upregulated
after a short period of IVM treatment (0.5 h) compared to the
number up-regulated after longer periods of treatment (1.5 and
2.5 h) in C. elegans (Ardelli and Prichard, 2013). These transient
responses suggest that the worm acts to quickly increase tran-
scription of transporter genes in response to drug exposure, and
then returns transcription to basal levels, having initiated the
process of synthesising transporter proteins.
The effects of exposure to IVM and LEV were very different forrra) to ivermectin following pre-exposure for 3 or 6 h to IVM (0.2 mg/mL and 0.8 mg/
6 h pre-exposure
IC50 Dose-response plateau
Drug conc.a mg/
mL
95% CI Drug/
DMSOa,b
Migrationc
(%)
95% CI Drug/
DMSOc,d
3.31 2.78
e3.93
e 15.5 9.6
e21.4
2.00* 1.56
e2.55
0.60* 18.0 12.6
e23.5
1.2
2.94 2.49
e3.47
0.89 25.4* 21.5
e29.2
1.6*
2.21 1.44
e3.40
0.67 31.3* 22.9
e39.7
2.0*
pre-exposure to anthelmintic was signiﬁcantly lower than the IC50 following pre-
lowing pre-exposure to DMSO.
he doseeresponse plateau following pre-exposure to anthelmintic was signiﬁcantly
ined by non-overlap of 95% Conﬁdence Intervals.
-exposure to anthelmintics/L3 migration (%) at the plateau for IVM following pre
Table 2
Response of third-stage larvae of the resistant isolate of Haemonchus contortus (Wallangarra) to levamisole following pre-exposure for 3 or 6 h to IVM (0.2 mg/mL and 0.8 mg/
mL) or LEV (0.4 mg/mL) in larval migration assays.
Pre-exposure Levamisole doseeresponse
3 h pre-exposure 6 h pre-exposure
IC50a 95% C.I Drug/DMSOa,b IC50a 95% C.I Drug/DMSOa,b
DMSO 0.95 0.81e1.11 e 0.83 0.71e0.98 e
IVM 0.2 mg/mL 0.47* 0.39e0.55 0.49* 0.36* 0.31e0.42 0.43*
IVM 0.8 mg/mL 0.31* 0.25e0.37 0.33* 0.36* 0.31e0.42 0.43*
LEV 0.4 mg/mL 0.27* 0.22e0.32 0.28* 0.27* 0.23e0.32 0.33*
a Within either the 3 or 6 h pre-exposure data sets:* denotes that the IC50 following pre-exposure to anthelmintic was signiﬁcantly lower than the IC50 following pre-
exposure to DMSO, as determined by non-overlap of 95% Conﬁdence Intervals.
b Drug/DMSO ¼ IC50 for LEV following pre-exposure to anthelmintics/IC50 for LEV following pre-exposure to DMSO.
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changes in transcription for any of the transporter genes at either
the 3 or 6 h time points. Of note however was the marked vari-
ability between replicate experiments for the susceptible L3 that
resulted in large SE bars, particularly at the 6 h time point. Hence,
although there were no signiﬁcant changes in transcription pat-
terns across the three replicate experiments, the non-signiﬁcant
increases in mean gene transcription values for many of the
transporters at the 6 h time point in the susceptible isolate,
alongside the greater variability at 6 h compared to the resistant
isolate, suggests that some up-regulation may have been occurring
in one ormore of our separate experiments. It remains possible that
the transcriptional response observed at 3 h with resistant L3 is
delayed in susceptible L3 such that the 6 h time point represents the
early stages of transcriptional response in this isolate. However, this
is speculative, and would require an examination of transcription
patterns at later time points to conﬁrm. Another possible expla-
nation for the observed variation between replicate experiments
for the susceptible isolate might be the slightly toxic effects of the
drugs under the experimental conditions. While the lower con-
centration of IVM and LEV showed about 12% inhibition of larval
migration (from Raza et al., 2015), the higher concentration of IVM
(0.8 mg/mL) inhibited larval migration by approximately 25%.
Hence, the larvae exposed to IVM at these concentrations may have
shown a degree of variability in their ﬁtness at the time of sampling
for transcription measurements.
We examined the effects of exposure to IVM and LEV on the rate
of R-123 efﬂux by the L3. Efﬂuxwas increased following exposure to
the higher concentration of IVM (0.8 mg/mL) and LEV in both
resistant and susceptible L3 despite the fact that the gene up-
regulation effects had only been observed with resistant L3. There
were no effects on R-123 efﬂux in both the isolates following
exposure to the lower concentration of IVM (0.2 mg/mL) (Fig. 8), in
contrast to the effect of this drug treatment in increasing the
transcription levels of a number of transporter genes in resistant L3
(Fig. 3C). These differences in the two measurements may be
explained by consideration of two aspects of the effects of exposure
to xenobiotics on ABC transporters, at the gene and protein levels:
ﬁrstly, at the gene level, the effects of drug exposure in increasing
transcription of transporter genes resulting in the generation of an
increased number of efﬂux proteins (Seelig, 1998), and, secondly,
the direct effect of xenobiotics in stimulating the activity of pre-
existing transporter proteins (Kerboeuf and Guegnard, 2011). This
latter study reported an increase in R-123 transport within a few
minutes after addition of anthelmintics in worm eggs. The authors
suggested that this was not compatible with up-regulation of P-gp
genes in such a short period, but rather was most likely due to
increased activity of transporter proteins present in the organism at
the start of the drug exposure period. As described above, our gene
transcription and R-123 experiments show a number of differencesin the responses of the two worm isolates to the two drugs at the
different time points. This indicates that the effects of drug expo-
sure on gene transcription and on R-123 efﬂux are not directly
correlated, thus suggesting that the increases in R-123 efﬂux
measured under our experimental conditions were at least partly
due to increases in the activity of existing transporter proteins, as
observed by Kerboeuf and Guegnard (2011), rather than as a
consequence of increased transcription.
We also studied the consequences of exposure to low levels of
IVM and LEV in terms of whether such exposure equipped the L3
with an ability to survive subsequent exposure to higher levels of
these same anthelmintics in migration assays. The assays were
performed using short incubation/migration periods (30 min for
both) compared to the 48 and 24 h periods usually used for this
assay (Kotze et al., 2006) in order to avoid any effects of the drugs in
possibly inducing transcription of the transporter genes during
such long incubation periods. The dose response curves showed the
presence of a plateau at the highest IVM concentrations. This was
most likely due to the short nature of both the drug incubation and
migration phases of the assay, and the subsequent inability to
inhibit migration completely in all larvae in this short time frame.
Such plateaus are not observed using standard longer time periods
(24e48 h) (Kotze et al., 2006; Raza et al., 2015). The presence of this
plateau allowed us to describe the response of the larvae to IVM in
terms of both the % migration at the plateau (the % of the popula-
tion able to migrate at the high IVM concentrations), as well as the
IC50 for the remainder of the population. We found that resistant L3
pre-exposed to IVM (at 0.8 mg/mL) or LEV showed an increased
tolerance to subsequent treatment with IVM in a proportion of the
population, as indicated by an increase in the percentage of the
population able to migrate at the highest drug concentrations. This
apparent tolerance to the drug only occurred in the proportion of
the population represented by the dose response plateau, as the
IC50 in the remainder of the population was either unchanged or
decreased compared to L3 pre-treated with DMSO alone (Table 1).
On the other hand there was no increase in this dose response
plateau at the lower IVM concentration (0.2 mg/mL) even though
this pre-treatment had resulted in greater fold increases in trans-
porter gene transcription. This contradiction may be at least partly
explained by examining the drug exposure data alongside both the
gene transcription and R-123 efﬂux data. Exposure to the higher
IVM concentration (0.8 mg/mL) and LEV resulted in increases in
both gene transcription and R-123 efﬂux, alongside an increased
ability to tolerate subsequent IVM exposure in a proportion of the
worm population (higher dose response plateau). On the other
hand, exposure to the lower IVM concentration resulted in
increased transcription levels, but no change in R-123 efﬂux,
alongside no increased drug tolerance. This suggests that, under
our experimental conditions, both the transcription and protein
activity responses are required in order to equip a proportion of the
Fig. 8. The effects of IVM (0.2 and 0.8 mg/mL) and LEV (0.4 mg/mL) pre-exposure for 3 h
on R-123 efﬂux in third-stage larvae of susceptible (A) and resistant (B) isolates of
Haemonchus contortus. R-123 efﬂux is expressed relative to controls (DMSO-treated).
Signiﬁcant differences in R-123 efﬂux compared to controls, within each isolate, are
indicated by * (P < 0.05). Data shown as mean ± SE, n ¼ 3 separate experiments, each
with assays in duplicate.
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Increases in transcription alone, in the absence of increased activity
of existing transporter proteins, as was observed with IVM at the
lower concentration, may not provide protection against drugs to a
degree measurable in our migration assays. We did not assess the
effects of exposure to IVM at 0.8 mg/mL on the subsequent ability of
susceptible L3 to the drug as exposure to this drug concentration
was previously shown to reduce migration by 25% (Raza et al.,
2015), hence making it difﬁcult to accurately measure the speciﬁceffects of subsequent drug exposure. The lack of drug tolerance
observed in susceptible L3 pre-exposed to IVM at 0.2 mg/mL
(Fig. 7A) would be expected given the lack of any increases in both
gene transcription and R-123 efﬂux (Figs. 3, 4, 5 and 8).
In contrast to the protective effects towards IVM of drug pre-
exposure in a proportion of the larval population for the resistant
isolate, as described above in terms of increases in the dose
response plateau, there were a number of instances of either no
change or a decrease in the IVM IC50 of the remainder of the pop-
ulation. An increase in sensitivity to LEV following pre-treatment
with IVM or LEV was also observed in most cases. In the absence
of any ABC transporter-mediated protection for at least a portion of
the population, as suggested above for IVM, a decreased tolerance
to a second drug exposure may be expected due to the cumulative
effects of sequential drug treatments. This may be particularly so
for sequential treatments with IVM and LEV given that macrocyclic
lactones have been reported to interact with nAChRs in vertebrates,
arthropods and nematodes (Krause et al., 1998; Raymond et al.,
2000; Carmichael et al., 2013; Abongwa et al., 2016). Hence, the
increased sensitivity of larvae to IVM or LEV following an initial
period of drug exposure to one of these drugs, compared to controls
exposed to the second drug alone, may be expected. It is the
reversal of this expected outcome, as observed in the cases of
increased tolerance to IVM as the second drug (Fig. 6A and B,
Table 1), that suggests the inﬂuence of a protective pathway
allowing the worms to show a degree of tolerance towards the
second drug. As mentioned above, tolerance to IVM in a component
of the larval population of the resistant isolate was accompanied by
either no change or an increase in sensitivity in the reminder of the
population. This suggests a degree of heterogeneity in the response
of the larvae to the drug pre-treatment. If, as we suggested above,
increased transporter activity is at least partly responsible for the
increased tolerance seen at the dose response plateau, then the
unchanged or decreased IVM IC50 values observed in the other
component of the worm population suggests that the gene
expression and R-123 efﬂux increases may also be quite hetero-
geneous across the worm population.
The difference in the responses of the resistant isolate to IVM
and LEV in the migration assay phase of these experiments (some
increased tolerance for IVM, none for LEV) suggests that, despite
the fact that pre-exposure to both drugs clearly leads to approxi-
mately equivalent up-regulation of a number of transporter genes,
and equivalent increases in R-123 efﬂux, the induced transporters
are able to subsequently provide protection only against IVM and
not LEV. This may suggest that IVM is a better substrate for the
H. contortus P-gs than LEV as reported earlier for mammalian P-gps
(Efferth and Volm, 1993) and, hence, the induced P-gps are more
effective in preventing the IVM interacting with its target site
compared to LEV.
In conclusion, the present study provides further evidence that
P-gps play a role in the interaction of anthelmintics with
H. contortus.We have shown that there is a great deal of variation in
the relative transcription levels of the different transporter genes in
this worm species, thereby suggesting an existence of variation in
their speciﬁc roles in protecting the worms from a range of xeno-
biotics. The constitutive over-expression of pgp-1, pgp-9.1 and pgp-
9.2 in Wallangra L3 suggests that these speciﬁc P-gps may play a
role in the anthelmintic resistance shown by this isolate. Further-
more, the increased transcription of some ABC transporters
following exposure to anthelmintics (IVM and LEV) indicates that
these anthelmintics interact with a number of speciﬁc H. contortus
ABC transporters and hence are likely to be the substrates for these
transporters. The presence of signiﬁcant levels of increased tran-
scription following 3 h exposure to both IVM and LEV in the
resistant isolate only, as well as stimulation of the existing
A. Raza et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 103e115114transport proteins, alongside the subsequent ability of a greater
proportion of the worm population to tolerate high IVM concen-
trations in larval migration assays, suggest that the ability to rapidly
up-regulate protective pathways in response to drugs may be a
component of the drug resistance displayed by this isolate, and
possibly by other drug-resistant nematodes. The variability seen in
the effects of pre-treatment with the two drugs on the sensitivity of
larvae in subsequent migration assays, with instances of increased
tolerance as well as increased sensitivity within the various treat-
ment groups, and even within single experimental populations,
suggests the presence of some heterogeneity in the observed re-
sponses to drug exposure in the resistant isolate. This indicates that
simple measurements of ABC transporter gene transcription levels
and efﬂux activities in preparations from whole larvae are not
necessarily indicative of the ability of transporter pathways to
protect worms from anthelmintics.
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